AI
Monday, December 09, 2024 10:08:50 AM
See this t-cell infiltration figure from neoadjuvant therapy of keytruda on rGBM in which Dr. Timothy Cloughesy and others found that administering keytruda prior to surgery can double OS than administering after surgery. The blue dots are cancer cells.
The following is the figure from the combo trial. Can you see the blue dots are a lot more than the above one? Do you know what it means?
It means that for the combo trial, complete resection of tumors may not be necessary.
Now refresh your memory about what I mentioned before.
Recent NWBO News
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
